Device Trial Radar · NCT05106491
Safety and Efficacy of Synchronized Cardiac Support (SCS) Versus Continuous Flow VA-ECMO in Cardiogenic Shock
Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
50
Planned (sponsor's estimate)
Start
Jan 2027
Primary completion
Jan 2029
Study completion Mar 2029
Sponsor
- Lead sponsor
- Xenios AGNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- IHF GmbH - Institut für Herzinfarktforschung
- First posted
- Nov 3, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study aims to investigate the efficacy of the Synchronized Cardiac Support treatment with the Novalung ultimate kit SCS in patients with cardiogenic shock in comparison with patients treated with continuous flow VA-ECMO
Conditions
- Cardiogenic Shock
- Extracorporeal Membrane Oxygenation
- ECLS
- VA ECMO
Interventions
Synchronized Cardiac Support with the Novalung ultimate kit SCSDevice
Patients receiving Synchronized Cardiac Support (SCS) treatment with the Novalung ultimate kit SCS and the Xenios 2.0 - Pulsatile flow
Control group: VA-ECMODevice
Patients receiving continuous flow VA-ECMO with the Novalung ultimate kit SCS and the Xenios 2.0 (Standard of care)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Cardiocirculatory stabilization and end-organ perfusionTime frame: Baseline and during the ECMO treatment up to 7 days
Locations
4 sites in 3 countries. Site status is shown where the registry gives one.
General University Hospital Prague
Prague, Czechia
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.